Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > National Dendrimer and Nano Center Attracts Emerging Bio Lab

CMU National Dendrimer and Nanotechnology Center Attracts Emerging Biotechnology Laboratory

Posted on January 06, 2006

A company developing biotechnologies for coatings and artificial cells that may treat many health conditions is locating a laboratory at Central Michigan University.

Initially, two researchers from Connecticut-based Artificial Cell Technologies Inc. will be located in CMU's Dow Science Complex. One ACT staff person has been at CMU since last summer.

In the future, ACT will join Dendritic NanoTechnologies Inc. and MultiGEN Diagnostics Inc. in relocating to a $5 million CMU wet lab facility that is supported by a $2.15 million U.S. Department of Commerce grant, $250,000 in Michigan Economic Development Corp. funding and $2.6 million from CMU.

The company is commercializing a new nanotechnology involving designed polypeptides that may lead to treatments for many health conditions and opportunities for research for CMU faculty and students.

Using technology originally developed at Louisiana Tech University, ACT designs, characterizes and produces complex, multilayer, nano-assembled polypeptide films, coatings and microcapsules. Peptides are natural or synthetic compounds containing two or more amino acids. Polypeptides are small proteins typically containing between 10 and 100 molecules of amino acids.

Among ACT's current research and development priorities are enantioselective filter membranes for pharmaceutical research and manufacturing, coatings for cell and tissue culture, and the encapsulation of hemoglobin to make artificial red blood cells. A safe, universally transfusible artificial red blood cell with a long life span in the body would transform human health, potentially eliminating blood supply shortages while also representing a new treatment modality for chronic conditions such as congestive heart disease, microvasculature disease and long-lasting anemias such as those caused by malaria.

ACT's technology also appears well suited to development of microcapsules for systemic or targeted drug delivery with tunable timed-release and other useful medical properties, multiantigen artificial virus vaccines, biocompatible coatings for medical devices and instruments, and antimicrobial coatings for food, food packaging or clothing.

ACT Chief Scientific Officer Don Haynie said that from the time of his first visit to CMU, he has been impressed with the capabilities of CMU's faculty and students, as well as the advanced equipment and facilities. The potential for synergistic relationships with other young technology firms at CMU's National Dendrimer and Nanotechnology Center, including Dendritic Nanotechnologies and Bio-ID Diagnostic, also appeals to Haynie.

"We are excited about the opportunity to be involved in bringing new educational opportunities to CMU while also leveraging the many scientific assets available within the central Michigan community to help ACT develop and commercialize our valuable products," said Haynie.

CMU students and faculty will have the opportunity to collaborate on projects and learn new skills through hands-on research experiences, including polypeptide synthesis and purification and the design and assembly of polypeptide nanostructures.

ACT Chief Executive Officer Tom Malone said, "The potential for achieving world-leading therapeutic and industrial advancements is greatly advanced by CMU's willingness to invest time, money and energy in fostering university-private company partnerships."

Malone also credited the support and vision of top officers at the university, valuable business services from the CMU Research Corp., and lower operating costs associated with research and development activities, when compared to the East Coast.

####
CMURC Contact:
Brent Case
(989) 774-1021
brent.case@cmich.edu

ACT Contact:
Thomas Malone
(203) 402-7209

Copyright © Central Michigan University

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Possible Futures

Virus structure inspires novel understanding of onion-like carbon nanoparticles April 10th, 2014

Local girl does good March 22nd, 2014

Surface Characteristics Influence Cellular Growth on Semiconductor Material March 12th, 2014

The "Tipping Point" February 12th, 2014

Investments/IPO's/Splits

Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014

Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014

Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014

Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Metabolon, Inc. April 7th, 2014

Nanomedicine

Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014

Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014

Innovative strategy to facilitate organ repair April 18th, 2014

High-temperature plasmonics eyed for solar, computer innovation April 17th, 2014

Materials/Metamaterials

Thinnest feasible membrane produced April 17th, 2014

INSCX™ exchange to present Exchange trade reporting mechanism for engineered nanomaterials (NMs) to UK regulation agencies, insurers and upstream/downstream users April 17th, 2014

Engineers develop new materials for hydrogen storage April 15th, 2014

Industrial Nanotech, Inc. Lands First Major Order from Pemex, Mexico’s State-Owned Oil and Gas Company April 14th, 2014

Announcements

Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014

Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014

'Exotic' material is like a switch when super thin April 18th, 2014

Innovative strategy to facilitate organ repair April 18th, 2014

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE